Agenus Inc.
NASDAQ:AGENBiotechnology
Healthcare
$6.14 -0.17%
-$0.01 today
- Market cap
- $277.81M
- Beta
- 1.54
- P/E (TTM)
- 1.7
- EPS (TTM)
- $1.70
52W Low $2.71High $7.34
Volume 0.82M
Average 0.82M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$158.31M
FY 2025 · Annual
Investing Cash Flow
$27,000.00
FY 2025 · Annual
+0.0% YoYFinancing Cash Flow
$122.84M
FY 2025 · Annual
+0.0% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (28.72M) | (230.66M) | (257.44M) | (232.27M) | (232.27M) |
| Depreciation & Amortization | 6.79M | 6.95M | 13.59M | 13.34M | 13.34M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 19.58M | 18.34M | 22.87M | 17.39M | 17.39M |
| Change in Working Capital | (9.74M) | 24.08M | 10.76M | 32.6M | 27.33M |
| Accounts Receivables | (394K) | 122K | (23.46M) | 25.34M | (1.73M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 10.82M | 6.49M | 21.37M | 2.01M | 23.5M |
| Other Working Capital | (20.17M) | 17.47M | 12.85M | 5.25M | 5.56M |
| Other Non-Cash Items | 22.25M | 5.92M | (13.98M) | 10.62M | 15.89M |
| Operating Cash Flow | 10.15M | (175.37M) | (224.2M) | (158.32M) | (158.32M) |
| Capital Expenditures | (33.81M) | (53.06M) | (9.95M) | (576K) | (576K) |
| Acquisitions (Net) | 0 | (2.92M) | 0 | 0 | 0 |
| Purchases of Investments | (14.99M) | (24.63M) | (20.04M) | 0 | 0 |
| Sales of Investments | 0 | 25M | 30.03M | 579K | 579K |
| Other Investing Activities | 5.66M | 22M | 3.36M | 24K | 24K |
| Investing Cash Flow | (43.15M) | (33.61M) | 3.4M | 27K | 27K |
| Debt Repayment | (1.32M) | (490K) | (8.93M) | 9.52M | 2.35M |
| Common Stock Issued | 220.65M | 99.21M | 133.16M | 38.82M | 36.31M |
| Common Stock Repurchased | (1.65M) | (3.79M) | (5.17M) | 0 | (87K) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 7.59M | 898K | 807K | 74.5M | 84.27M |
| Financing Cash Flow | 225.26M | 95.83M | 119.87M | 122.84M | 122.84M |
| Effect of Forex Changes | (164K) | (104K) | (628K) | (260K) | (260K) |
| Net Change in Cash | 192.1M | (113.26M) | (101.56M) | (35.71M) | (35.71M) |
| Free Cash Flow | (23.67M) | (228.44M) | (234.16M) | (158.89M) | (158.89M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$232.3M
+ D&A$13.3M
+ Stock-Based Comp$17.4M
+ Deferred Tax$0
+ Working Capital$27.3M
+ Other Non-Cash$15.9M
= Operating Cash Flow-$158.3M
- Capex-$576.0K
= Free Cash Flow-$158.9M
Analysis
FY2025 free cash flow is -$158.9M. FCF conversion is 68.4% of net income. Operating cash flow was -$158.3M, with capex of -$576.0K. The largest bridge item is Working Capital at $27.3M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Nov 13, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 2, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 2, 2026 |
Does AGEN generate free cash flow?
Agenus Inc. (AGEN) generated -$158.89M of free cash flow in fiscal 2025.
How much operating cash flow does AGEN produce?
Operating cash flow was -$158.31M, before capital expenditures of $576,000.00.
Continue the stock analysis
Jump to another research area for this company.